WS #10985

10:25→10:52 UTC
From 500 msgs · 6 key-dev

Bloomberg reports Zymeworks near $929M deal for Theravance at $17/share, a significant biotech M&A signal.

M&A Activity: Zymeworks-Theravance

Bloomberg reports Zymeworks near $929M deal for Theravance at $17/share, a significant biotech M&A signal.

Full world state #10985 →

Russia-Ukraine Energy War EscalationChina-Japan Trade TensionsBitcoin Technical Weakness
← WS #10984WS #10986 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|